Google News – Pharmaceuticals External News
Life Sciences & Pharma Articles
Google News – FDA (biotech/pharma) External News
Takeda receives US FDA approval of Mimrylo - The Pharma Letter
Google News – Cardiology External News
ESC: AZ, Ionis' Wainua post-mortem throws water on silencer-plus-stabilizer approach in ATTR-CM - fiercepharma.com
Google News – FDA (biotech/pharma) External News
FDA withdraws action on Pune Cipla unit, MCA eateries after HC rebuke - Rediff
Google News – Clinical Trials External News
Cytokinetics drug outperformed metoprolol in a 175-patient heart trial - Stock Titan
Google News – FDA (biotech/pharma) External News
Going overboard: HC raps FDA over Cipla Pune licence cancellation; order withdrawn - India Today
Google News – FDA (biotech/pharma) External News
'Now you are going overboard': After Bombay high court rap, FDA withdraws order cancelling licence of Cipla Pharma | India News - Hindustan Times
Google News – FDA (biotech/pharma) External News
Cipla Pharma license cancellation: FDA withdraws order after HC raps it for going 'overboard' - The Economic Times
Industry News External News
Cipla Pharma license cancellation order withdrawn as HC chides Maharashtra FDA - BusinessLine
Industry News External News
Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Govt - BusinessLine
Google News – Pharmaceuticals External News
White House announces nearly a dozen new drug pricing deals with pharmaceutical companies - MS NOW
Google News – Biopharma External News
GTBP stock holds steady as GT Biopharma advances TriKE cancer pipeline - AD HOC NEWS
Google News – FDA (biotech/pharma) External News
FDA cancels drug sale licences of Cipla Pharma’s Pune unit over violations | Hindustan Times - Hindustan Times
Google News – FDA (biotech/pharma) External News
Takeda bolsters blood cancer portfolio with FDA nod for Mimrylo in polycythemia vera - Fierce Pharma
Google News – NIH External News